Effect of lamivudine against HBV reinfection after liver transplantation
Shichun Lu(Hefei University of Technology), Xiuhui Zhang, Bo Li(Capital Medical University), Jun Liu(Jinan University), Xiaodong Li(Shenzhen Luohu People's Hospital), Xiaobo Wang(Columbia University Irving Medical Center), Chong Liu(Second Military Medical University), Jichun Zhao, Nan-Sheng Cheng, Bin-Jun Lei, Shan Qin(Chinese Academy of Sciences), Tianfu Wen(Sichuan University), Lünan Yan(National Cancer Center), Lian-Shan Zhao
Cited by 0
Related Papers
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
|Journal of Clinical Oncology|2013|775
The role of hepatic resection in the treatment of hepatocellular cancer
|Hepatology|2015|415
Targeted Delivery of CRISPR/Cas9‐Mediated Cancer Gene Therapy via Liposome‐Templated Hydrogel Nanoparticles
|Advanced Functional Materials|2017|297
Efficient Strategies for Microglia Replacement in the Central Nervous System
|Cell Reports|2020|172